| 2022-08-04 6:54:1 am |
Thinking about buying stock in ChemoCentryx, Invivo Therapeutics, Greenlight Biosciences, Missfresh, or NanoViricides? |
PRNewsWire |
| Aug-04-22 09:01AM |
NanoViricides shares soar 41% after announcing plans to develop a monkeypox treatment |
MarketWatch |
| Aug-04-22 06:45AM |
NanoViricides Reports That It Has Begun Drug Development to Combat Monkeypox Virus |
ACCESSWIRE |
| May-17-22 06:45AM |
NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2022 - Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Progressing Further for Clinical Trials Application |
ACCESSWIRE |
| May-16-22 12:22PM |
NanoViricides Starts Drug Development Program For Recent Cases Of Unexplained Pediatric Hepatitis |
Benzinga |
| May-16-22 06:45AM |
NanoViricides Reports that It Has Begun Drug Development to Combat Recent Cases of Severe Pediatric Hepatitis |
ACCESSWIRE |
| Apr-25-22 06:45AM |
NanoViricides Provides Update On NV-CoV-2 Coronavirus Drug Candidate Program |
ACCESSWIRE |
| Feb-15-22 06:45AM |
NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2021 - Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Clinical Trials Application Ready |
ACCESSWIRE |
| Nov-16-21 06:45AM |
NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards Clinical Trials |
ACCESSWIRE |
| Nov-15-21 07:31AM |
EXCLUSIVE: NanoViricides Completes Oral Gummies, Lung Inhalation Formulations For COVID-19 Treatment |
Benzinga |
| Nov-15-21 06:45AM |
NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2 |
ACCESSWIRE |
| Nov-15-21 06:18AM |
EXCLUSIVE: NanoViricides Develops Chewable Pills, Lung Inhalation Formulations For COVID-19 Candidate |
Benzinga |
| Oct-13-21 06:45AM |
NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage |
ACCESSWIRE |
| Oct-11-21 08:25AM |
NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity |
Benzinga |
| Oct-11-21 06:45AM |
NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity |
ACCESSWIRE |
| Oct-05-21 08:31AM |
NanoViricides Leaps Forward in its Quest to Defeat COVID-19 |
Benzinga |
| Oct-05-21 06:45AM |
NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference |
PR Newswire |
| Sep-28-21 09:28AM |
Company News for Sep 28, 2021 |
Zacks |
| Sep-27-21 07:02AM |
20 Stocks Moving in Monday's Pre-Market Session |
Benzinga |
| Sep-27-21 06:45AM |
NanoViricides, Inc. Invites You to Join Us at the Benzinga Healthcare Small Cap Conference for Update on Pan-Coronavirus COVID-19 Drug Development Program |
Newsfile |
| Sep-22-21 06:45AM |
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug |
PR Newswire |
| Sep-22-21 06:45AM |
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug |
CNW Group |
| Sep-21-21 02:18PM |
Nanoviricides Stock Surges, Nears The End Of A Pennant Pattern |
Benzinga |
| Sep-14-21 12:04PM |
36 Stocks Moving In Tuesday's Mid-Day Session |
Benzinga |
| Sep-14-21 07:32AM |
NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development |
Benzinga |
| Sep-14-21 06:45AM |
NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development |
PR Newswire |
| Jun-28-21 08:28AM |
Nanomedicine Company Makes "Nanomachines" that Attack Viruses |
Benzinga |
| Jun-22-21 12:49PM |
NanoViricides Review: What you Need to Know About the Company |
Benzinga |
| May-17-21 06:45AM |
NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards IND |
ACCESSWIRE |
| Mar-09-21 08:08AM |
The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data |
Benzinga |
| Mar-09-21 05:45AM |
NanoViricides, Inc. Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in Support of FDA Pre-IND Application |
ACCESSWIRE |
| Mar-02-21 08:01AM |
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data |
Benzinga |
| Mar-02-21 06:15AM |
NanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application |
ACCESSWIRE |
| Mar-02-21 04:43AM |
NanoViricides Reports 'Strong Effectiveness' for COVID Drugs |
TheStreet.com |
| Feb-18-21 04:59AM |
We're Hopeful That NanoViricides (NYSEMKT:NNVC) Will Use Its Cash Wisely |
Simply Wall St. |
| Feb-17-21 06:15AM |
NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 - Has Sufficient Cash, Coronavirus Drug Candidate Safe in GLP Safety Toxicology Moving Towards IND |
ACCESSWIRE |
| Feb-08-21 07:40AM |
NanoViricides' Broad-Spectrum Antiviral Drug Candidate Shows Encouraging Action In Preclinical Studies For COVID-19 |
Benzinga |
| Feb-08-21 06:15AM |
NanoViricidess Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies |
ACCESSWIRE |
| Jan-27-21 06:15AM |
Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.s President, Dr. Anil Diwan |
ACCESSWIRE |
| Nov-19-20 06:20AM |
NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA |
ACCESSWIRE |
| Nov-18-20 11:49AM |
Small Caps Daily Features NanoViricides' Rapid Advancement to Clinical Trials for its COVID-19 Therapy |
Newsfile |
| Nov-17-20 06:20AM |
NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2020 - Has Sufficient Cash, Coronavirus Drug Development Progress |
ACCESSWIRE |
| Nov-11-20 10:55AM |
NanoViricides: One Step at a Time |
GuruFocus.com |
| Nov-11-20 06:20AM |
NanoViricides Has Engaged Calvert Labs for Safety Pharmacology Studies of Its Drug for the Treatment of COVID-19 |
ACCESSWIRE |
| Oct-15-20 06:15AM |
NanoViricides, Inc. Has Filed its Annual Report: Strengthened Financial Position and Rapidly Developing Novel Coronavirus Drug Program |
ACCESSWIRE |
| Sep-18-20 05:35PM |
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NanoViricides, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm |
Business Wire |
| Sep-16-20 06:15AM |
NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19 |
ACCESSWIRE |
| Sep-08-20 09:10AM |
NanoViricides, Inc. Investors Who Purchased NNVC Securities Between January 23, 2020 and July 13, 2020 And Suffered Significant Losses Encouraged To Contact Kehoe Law Firm, P.C. |
PR Newswire |
| Sep-04-20 06:50AM |
NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference |
ACCESSWIRE |
| Sep-02-20 06:15AM |
NanoViricides to Present COVID-19 Drug Update at The LD 500 Virtual Conference |
ACCESSWIRE |
| Aug-31-20 05:00PM |
(LD Micro) 360 Companies Set to Present this Week |
ACCESSWIRE |
| Aug-31-20 08:40AM |
Small Caps Daily Features NanoViricides' Progress on Developing a Therapy To Help Kids Return To School Safely |
Newsfile |
| Aug-06-20 01:43PM |
LD Micro: Announces Preliminary List of Presenters for the LD-500 |
ACCESSWIRE |
| Jul-23-20 11:48AM |
NanoViricides, Inc. Raises $11.5 Million Through Public Offering After Positive Test Results For COVID-19 Drug |
Newsfile |
| Jul-21-20 06:15AM |
NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020 |
ACCESSWIRE |
| Jul-20-20 06:10PM |
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds NanoViricides (NNVC) Investors of Proprietary Investigation into Possible Securities Law Violations, Encourages Investors and Persons Who May be Able to Assist Investigation to Contact Firm |
GlobeNewswire |
| Jul-16-20 03:16PM |
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Announces Investigation of NanoViricides, Inc. (NNVC) on Behalf of Investors |
Business Wire |
| Jul-16-20 10:52AM |
NanoViricides, Inc. Investors Who Purchased NNVC Securities After January 2020 And Suffered Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C. |
GlobeNewswire |
| Jul-13-20 06:30AM |
NanoViricides Closes On $11.5 Million Underwritten Public Offering of Common Stock |
ACCESSWIRE |
| Jul-09-20 06:15AM |
NanoViricides Prices $10.0 Million Underwritten Public Offering of Common Stock |
ACCESSWIRE |
| Jul-08-20 05:55PM |
Nanoviricides Commences Underwritten Public Offering of Common Stock |
ACCESSWIRE |
| Jul-08-20 05:50PM |
Covid-19 Research Update: The Stars and the Question Marks |
GuruFocus.com |
| Jul-08-20 06:15AM |
Safety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides SARS-CoV-2 Therapeutics Program |
ACCESSWIRE |
| Jun-30-20 06:15AM |
NanoViricides Announces Addition to Russell Microcap(R) Index |
ACCESSWIRE |
| Jun-25-20 11:05AM |
NanoViricides: Sufficient Funding for Covid-19 Research |
GuruFocus.com |
| Jun-23-20 06:15AM |
NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2020 - Has Sufficient Cash, Progress on New Coronavirus Drug Program and the Lead HerpeCide(TM) Drug Candidate IND Application |
ACCESSWIRE |
| Jun-09-20 07:46AM |
The Daily Biotech Pulse: Soleno Flunks Late-Stage Study, Sanofi Strikes Breast Cancer Partnership, NanoViricides Shortlists Coronavirus Treatment Candidates |
Benzinga |
| Jun-09-20 06:15AM |
NanoViricides Signs Memorandum of Understanding for Human Coronavirus Drug Development License |
ACCESSWIRE |
| May-26-20 06:15AM |
NanoViricides Announces Completion of $10.2 Million Registered Direct Offering - Funds to Accelerate COVID-19 Drug Program and HerpeCide Program |
ACCESSWIRE |
| May-21-20 08:30AM |
NanoViricides Announces Pricing of $10.2 Million Registered Direct Offering |
ACCESSWIRE |
| May-20-20 06:15AM |
Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus |
ACCESSWIRE |
| May-18-20 06:15AM |
Honorable Ex-Congressman Todd Rokita Joins the Board of Directors of NanoViricides, Inc. |
ACCESSWIRE |
| May-13-20 10:12AM |
Company News for May 13, 2020 |
Zacks |
| May-12-20 12:57PM |
NanoViricides: New Covid-19 Drug Candidates Could Boost Performance |
GuruFocus.com |
| May-12-20 06:15AM |
NanoViricides Develops Highly Effective Broad-Spectrum Drug Candidates Against Coronaviruses |
ACCESSWIRE |
| May-04-20 06:15AM |
NanoViricides Signs Confidential Disclosure Agreement with International Pharmaceutical Company to Explore Collaborating on its COVID-19 Program |
ACCESSWIRE |
| Apr-29-20 06:15AM |
NanoViricides Presentation on COVID-19 and Shingles Drug Development Update at the Planet MicroCap Showcase Virtual Investor Conference 2020 is Now Available |
ACCESSWIRE |
| Apr-21-20 02:00PM |
NanoViricides to Present COVID-19 and Shingles Drug Development Update at the Planet MicroCap Showcase Virtual Investor Conference 2020 on April 22nd |
ACCESSWIRE |
| Apr-13-20 06:15AM |
NanoViricides President Dr. Anil Diwan was Interviewed by Proactive Investors About the Companys Antiviral Drug Development Against SARS-CoV-2 to Treat COVID-19 |
ACCESSWIRE |
| Apr-07-20 02:31PM |
Does NanoViricides, Inc. (NYSEMKT:NNVC) Have A High Beta? |
Simply Wall St. |
| Apr-07-20 11:49AM |
NanoViricides: The Visit From Senator Blumenthal Is a Positive Development |
GuruFocus.com |
| Apr-06-20 06:15AM |
U.S. Senator Richard Blumenthal Visited NanoViricides Inc. for Update on Coronavirus (COVID-19) Drug Development Efforts |
ACCESSWIRE |
| Mar-31-20 07:30AM |
NanoViricides, Inc. Progress on COVID-19 Drug Encouraging |
Newsfile |
| Mar-16-20 06:15AM |
Coronavirus Drug Development Update from NanoViricides, Inc. |
ACCESSWIRE |
| Mar-14-20 10:18AM |
Inovio stock rallies after company gets Gates Foundation grant to test device for coronavirus vaccine |
MarketWatch |
| Mar-13-20 05:42PM |
The Coronavirus Pandemic Has Revealed Some Micro-Cap Opportunities |
GuruFocus.com |
| Mar-09-20 02:44PM |
Is Inovio Pharmaceuticals Stock the Cure for Your Portfolio? |
InvestorPlace |
| Mar-05-20 04:11PM |
NanoViricides, Inc. Reports Discovery of Broad-Spectrum Virus-Binding Ligands; Expected to Counter COVID-19 |
Newsfile |
| Feb-28-20 04:57PM |
Dow, S&P 500 fall for 7th straight day; stocks suffer biggest weekly fall since 2008 |
MarketWatch |
| Feb-25-20 03:25PM |
18 Medical Stocks To Watch Amid The Coronavirus Outbreak |
Benzinga |
| Feb-24-20 08:39AM |
NanoViricides stock soars amid fears of global spread of COVID-19 |
MarketWatch |
| Feb-24-20 08:04AM |
Benzinga Pro's Top 5 Stocks To Watch For Mon., Feb. 24, 2020: NNVC, WFC, SPCE, LL, CETX |
Benzinga |
| Feb-24-20 06:15AM |
NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2019 - Has Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress |
ACCESSWIRE |
| Feb-18-20 01:01PM |
The Wuhan Virus and Research-Focused Biotech Companies |
GuruFocus.com |
| Feb-12-20 06:15AM |
Dr. Mak Jawadekar Joins the Board of Directors of NanoViricides, Inc. |
ACCESSWIRE |
| Feb-10-20 07:30AM |
Nanoviricides President Dr. Diwan Was Interviewed by The Varney Show on Fox Business News |
ACCESSWIRE |
| Feb-06-20 05:50PM |
Can Biotech ETFs Continue to Soar in 2020? |
Zacks |
| Feb-04-20 07:30AM |
Nanoviricides President Dr. Diwan Was Interviewed By The Kennedy Show On Fox Business News |
ACCESSWIRE |
| Feb-03-20 02:17PM |
Coronavirus update: 361 have died, there are now 11 cases in the U.S. and the case count has doubled SARS |
MarketWatch |
| Feb-03-20 08:59AM |
Benzinga Pro's Top 5 Stocks To Watch For Mon., Feb. 3, 2020: SYY, PCG, NNVC, UBER, TSLA |
Benzinga |
| Feb-01-20 10:53AM |
Coronavirus update: WHO says prepare for local coronavirus outbreaks in other countries |
MarketWatch |